Clinical trial

Aldosterone, the Mineralocorticoid Receptor, and Cardiovascular Disease in Obesity

NCT04519164

Drugs and interventions used in this trial

2 registered

These interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.

Search this trial's interventions

DRUG · Mapped RxNorm record Eplerenone Normalized identity: eplerenoneView linked drug · Find medicine records · Find other trials using this name

DRUG · Unmapped registry intervention Chlorthalidone with potassium chloride Find medicine records · Find other trials using this name

Study at a glance

Registry-backed

Aldosterone, the Mineralocorticoid Receptor, and Cardiovascular Disease in Obesity

Design: INTERVENTIONAL · Status: COMPLETED · Phase: PHASE4

Read study objectives, eligibility and outcome measures at ClinicalTrials.gov

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2020-12-01

PhasePHASE4

Conditions

Metabolic Syndromeverified · MONDO: abdominal obesity-metabolic syndrome

Hypertensionunresolved

Overweight and Obesityunresolved

Interventions

EplerenoneDRUG · verified · RxNorm: eplerenone

Chlorthalidone with potassium chlorideDRUG

Sponsors & collaborators

Brigham and Women's Hospitallead sponsor

Mapped research locations

BostonMassachusetts, United States1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT04519164 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.